Anthony Jon Ferretti, DO | |
5401 Peach St, Suite 3300, Erie, PA 16509-2601 | |
(814) 868-7840 | |
(814) 868-2139 |
Full Name | Anthony Jon Ferretti |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 30 Years |
Location | 5401 Peach St, Erie, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043275233 | NPI | - | NPPES |
0017934880005 | Medicaid | PA | |
0017934880004 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | OS08877L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Millcreek Community Hospital | Erie, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medical Associates Of Erie | 2769402783 | 46 |
Corry Memorial Hospital Association | 3971581174 | 23 |
Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
Millcreek Community Hospital | 8426020173 | 38 |
News Archive
CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana.
Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Knowledge regarding environmental factors influencing the risk of Alzheimer's disease is surprisingly scarce, despite substantial research in this area. In particular, the roles of smoking and alcohol consumption still remain controversial. A new study published this month in the Journal of Alzheimer's Disease suggests a protective effect of alcohol consumption on the risk of Alzheimer's disease, particularly in women who do not smoke.
› Verified 8 days ago
Entity Name | Medical Associates Of Erie |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649205816 PECOS PAC ID: 2769402783 Enrollment ID: O20051205000786 |
News Archive
CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana.
Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Knowledge regarding environmental factors influencing the risk of Alzheimer's disease is surprisingly scarce, despite substantial research in this area. In particular, the roles of smoking and alcohol consumption still remain controversial. A new study published this month in the Journal of Alzheimer's Disease suggests a protective effect of alcohol consumption on the risk of Alzheimer's disease, particularly in women who do not smoke.
› Verified 8 days ago
Entity Name | Corry Memorial Hospital Association |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1518411677 PECOS PAC ID: 3971581174 Enrollment ID: O20160928002194 |
News Archive
CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana.
Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Knowledge regarding environmental factors influencing the risk of Alzheimer's disease is surprisingly scarce, despite substantial research in this area. In particular, the roles of smoking and alcohol consumption still remain controversial. A new study published this month in the Journal of Alzheimer's Disease suggests a protective effect of alcohol consumption on the risk of Alzheimer's disease, particularly in women who do not smoke.
› Verified 8 days ago
Entity Name | Corry Memorial Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124406376 PECOS PAC ID: 3971581174 Enrollment ID: O20170727002362 |
News Archive
CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana.
Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Knowledge regarding environmental factors influencing the risk of Alzheimer's disease is surprisingly scarce, despite substantial research in this area. In particular, the roles of smoking and alcohol consumption still remain controversial. A new study published this month in the Journal of Alzheimer's Disease suggests a protective effect of alcohol consumption on the risk of Alzheimer's disease, particularly in women who do not smoke.
› Verified 8 days ago
Entity Name | Millcreek Community Hospital |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1952935892 PECOS PAC ID: 8426020173 Enrollment ID: O20200618001333 |
News Archive
CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana.
Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Knowledge regarding environmental factors influencing the risk of Alzheimer's disease is surprisingly scarce, despite substantial research in this area. In particular, the roles of smoking and alcohol consumption still remain controversial. A new study published this month in the Journal of Alzheimer's Disease suggests a protective effect of alcohol consumption on the risk of Alzheimer's disease, particularly in women who do not smoke.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Anthony Jon Ferretti, DO 1 Lecom Pl, Erie, PA 16505-2571 Ph: () - | Anthony Jon Ferretti, DO 5401 Peach St, Suite 3300, Erie, PA 16509-2601 Ph: (814) 868-7840 |
News Archive
CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana.
Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
Thanks to improved surgical, pain management and rehabilitation procedures, patients who undergo a total hip replacement (THR) may be able to safely drive as early as two weeks following surgery, according to new research presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
Knowledge regarding environmental factors influencing the risk of Alzheimer's disease is surprisingly scarce, despite substantial research in this area. In particular, the roles of smoking and alcohol consumption still remain controversial. A new study published this month in the Journal of Alzheimer's Disease suggests a protective effect of alcohol consumption on the risk of Alzheimer's disease, particularly in women who do not smoke.
› Verified 8 days ago
Joshua Alan Tuck, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5401 Peach St, Suite 3300, Erie, PA 16509 Phone: 814-868-7840 Fax: 814-868-2139 | |
Dr. Richard Arthur Rahner, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1234 Saint Ann Dr, Erie, PA 16509 Phone: 814-864-8002 | |
Dr. Arjun Suresh Malhotra, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 5515 Peach St, Erie, PA 16509 Phone: 814-864-4031 | |
Gary Cortina, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 State St Fl 4, 4th Floor, Suite 401, Erie, PA 16507 Phone: 814-877-8370 | |
Dr. Drew Miller, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 5515 Peach St, Erie, PA 16509 Phone: 814-864-4031 | |
Mark T Bloomstine, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2315 Myrtle St Ste L10, Erie, PA 16502 Phone: 814-454-2401 Fax: 814-459-5992 |